3-48847365-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_004157.4(PRKAR2A):​c.232A>G​(p.Ser78Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

PRKAR2A
NM_004157.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.26
Variant links:
Genes affected
PRKAR2A (HGNC:9391): (protein kinase cAMP-dependent type II regulatory subunit alpha) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. It may interact with various A-kinase anchoring proteins and determine the subcellular localization of cAMP-dependent protein kinase. This subunit has been shown to regulate protein transport from endosomes to the Golgi apparatus and further to the endoplasmic reticulum (ER). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity KAP2_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08790645).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRKAR2ANM_004157.4 linkuse as main transcriptc.232A>G p.Ser78Gly missense_variant 1/11 ENST00000265563.13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRKAR2AENST00000265563.13 linkuse as main transcriptc.232A>G p.Ser78Gly missense_variant 1/111 NM_004157.4 P1P13861-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 24, 2023The c.232A>G (p.S78G) alteration is located in exon 1 (coding exon 1) of the PRKAR2A gene. This alteration results from a A to G substitution at nucleotide position 232, causing the serine (S) at amino acid position 78 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.032
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
16
DANN
Benign
0.75
DEOGEN2
Benign
0.23
T;T;.;.
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.084
N
LIST_S2
Benign
0.67
.;T;T;T
M_CAP
Benign
0.067
D
MetaRNN
Benign
0.088
T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.7
L;L;L;.
MutationTaster
Benign
0.77
N;N;N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Benign
0.26
Sift
Benign
0.11
T;T;T;D
Sift4G
Benign
0.41
T;T;T;.
Polyphen
0.0
B;B;.;.
Vest4
0.098
MutPred
0.19
Loss of phosphorylation at S78 (P = 0.0018);Loss of phosphorylation at S78 (P = 0.0018);Loss of phosphorylation at S78 (P = 0.0018);Loss of phosphorylation at S78 (P = 0.0018);
MVP
0.75
MPC
0.34
ClinPred
0.15
T
GERP RS
0.54
Varity_R
0.060
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-48884798; API